Multiple lines of evidence indicate that serotonin ) and voltage-gated K ϩ (K V ) channels play a central role in the pathogenesis of pulmonary hypertension (PH). We hypothesized that 5-HT might modulate the activity of K V channels, therefore establishing a link between these pathogenetic factors in PH. Here, we studied the effects of 5-HT on K V channels present in rat pulmonary artery smooth muscle cells (PASMC) and on hK V 1.5 channels stably expressed in Ltk Ϫ cells. 5-HT reduced native K V and hK V 1.5 currents, depolarized cell membrane, and caused a contraction of isolated pulmonary arteries. The effects of 5-HT on K V currents and contraction were markedly prevented by the 5-HT 2A receptor antagonist ketanserin. Incubation with inhibitors of phospholipase C (U73122), classic protein kinase Cs (Gö6976), or tyrosine kinases (genistein and tyrphostin 23), the cholesterol depletion agent ␤-cyclodextrin or concanavalin A, an inhibitor of endocytotic processes, also prevented the effects of 5-HT. In homogenates from pulmonary arteries, 5-HT 2A receptors and caveolin-1 coimmunoprecipitated with K V 1.5 channels, and this was increased on stimulation with 5-HT. Moreover, K V 1.5 channels were internalized when cells were stimulated with 5-HT, and this was prevented by concanavalin A. These findings indicate that activation of 5-HT 2A receptors inhibits native K V and hK V 1.5 currents via phospholipase C, protein kinase C, tyrosine kinase, and a caveolae pathway. K V channel inhibition accounts, at least partly, for 5-HT-induced pulmonary vasoconstriction and might play a role in PH. (Circ Res. 2006;98:931-938.) 
P ulmonary hypertension (PH) is a heterogeneous group of disorders characterized by a sustained increase in pulmonary artery (PA) pressure leading to progressive right ventricular failure and death. Several lines of evidence indicate that serotonin (5-hydroxytryptamine ) plays a central role in the pathogenesis of PH. 1, 2 First, 5-HT is an effective pulmonary vasoconstrictor and induces vascular smooth muscle hyperplasia. [2] [3] [4] [5] Moreover, plasma levels of 5-HT are increased in patients with primary PH. 6 Conversely, mild pulmonary hypertension has been reported in some series of patients with carcinoid syndrome, a tumor of enterochromaffin cells releasing large amounts of 5-HT. 7 Patients treated with fenfluramine or dexfenfluramine, anorectic drugs that induce platelet 5-HT release, inhibit the 5-HT transporter (5-HTT) and stimulate 5-HT receptors, also have a 23-fold increased risk of PH. 8 In addition, 5-HTT overexpression or polymorphisms in the gene encoding the 5-HTT are associated with PH. 9, 10 Furthermore, mice lacking 5-HTT or 5-HT receptors (eg, 5-HT 1B or 5-HT 2B ) show attenuated PH induced by hypoxia. 3, 11, 12 Finally, specific pharmacological inhibition of 5-HT 1B or 5-HT 2A receptors or 5-HTT attenuates and/or reverses the development of PH and prolongs survival in animal models of PH. 3, [12] [13] [14] [15] K ϩ channels play an essential role in regulating resting membrane potential, intracellular calcium concentration ([Ca 2ϩ ] i ), and contraction of vascular smooth muscle. 16 -18 Activation of K ϩ channels leads to hyperpolarization, whereas their inhibition causes membrane depolarization, activation of voltage-gated L-type Ca 2ϩ channels, increase in [Ca 2ϩ ] i , and vasoconstriction. Voltage-gated K ϩ (K V ) channels present in pulmonary artery smooth muscle cells (PASMC) are inhibited by hypoxia, endothelin-1, thromboxane A 2 , and anorectic drugs. 16,19 -21 Moreover, decreased expression or function of K V channels in PASMC has been involved in the pathogenesis of primary and anorexigeninduced PH. 21, 22 From the variety of K V channels expressed in PASMC, special interest has been paid to K V 1.5, because decreased expression or activity and mutations of K V 1.5 occurs in primary PH 22, 23 and in vivo gene transfer of K V 1.5 reduces PH and restores hypoxic pulmonary vasoconstriction. 24 Furthermore, decreased expression and function of K V channels in PASMC leads to inhibition of apoptosis and promotes pulmonary vascular medial hypertrophy, 25 whereas upregulation of K V 1.5 correlates with an increase in apoptosis/proliferation ratio and prevents and reverses PH. 26 As stated above, both 5-HT and K V channels may have an etiological role in PH. Unfortunately, the effects of 5-HT on K V channels in PASMC have not been analyzed yet. We hypothesized that 5-HT might inhibit K V channels, thereby establishing a link between these 2 pathogenic pathways in PH. Therefore, in the present study we have analyzed the effects of 5-HT on the current flowing through K V channels (I K(V) ) recorded in rat PASMC and through cloned hK V 1.5 channels (I KV1.5 ) stably expressed in Ltk Ϫ cells. The role of 5-HT receptors and 5-HTT in 5-HT-induced effects has also been studied.
Materials and Methods
All experiments were performed in accordance with the European Animals Act 1986 (Scientific Procedures) and approved by our institutional review board. A detailed description of the experimental methods is available in the online data supplement at http://circres.ahajournals.org.
Second-to third-order branches of the PA isolated from male Wistar rats were dissected and denuded of endothelium and PASMC were enzymatically isolated. Membrane currents were recorded in PASMC or in Ltk Ϫ cells stably expressing hK V 1.5 channels using the whole-cell configuration of the patch-clamp technique and membrane potential was measured under current-clamp configuration. 19, 27 Coimmunoprecipitation, confocal immunostaining, and contractile tension studies are described in the online data supplement.
Results

Effects of 5-HT on I K(V) and Membrane Potential in PASMC
Addition of 5-HT (10 mol/L) markedly inhibited I K(V) at all potentials tested ( Figure 1A and 1B) and depolarized PASMC ( Figure 1D ) (PϽ0.01). The concentration-response curve for the inhibition of I K(V) by 5-HT at test potentials of Ϫ30 and ϩ60 mV was fitted to a Hill equation leading to E max values of 41.2Ϯ3.4% and 50.2Ϯ0.5% and EC 50 of 1.23Ϯ0.42 and 2.33Ϯ0.09 mol/L, respectively ( Figure 1C ), indicating a voltage-independent inhibition. K V currents recorded before and after treatment with 5-HT showed similar activation kinetics and voltage-activation curves (supplemental Figure  I ). After washing with 5-HT-free solution for 10 to 15 minutes, the effects of 5-HT on K V currents (nϭ5; not shown) or on membrane potential ( Figure 1D ; nϭ3) were only weakly or not reversed. In contrast, the effects of the K V channel blocker 4-aminopyridine (4-AP) (3 mmol/L) on K V currents (not shown; nϭ3) or on membrane potential were reversed by Ϸ80% following a 5 minutes washing period ( Figure 1E ; nϭ3).
To test the involvement of 5-HT 2A receptor on the I K(V) blocking properties of 5-HT, we performed experiments in the presence of the selective 5-HT 2A receptor antagonist ketanserin (0.1 mol/L). This drug had negligible effects on I K(V) but inhibited the effects of 5-HT on I K(V) ( Figure 2 ) and on membrane potential (Ϫ46.3Ϯ2.1 and Ϫ45.2Ϯ2.1 before and after 5-HT, respectively; nϭ4). Similarly, the inhibitory effect of 5-HT on I K(V) was markedly attenuated in the presence of the 5-HTT inhibitor fluoxetine (0.1 mol/L, Figure 2C ; current-voltage [I-V] relationship in supplemental Figure II ). However, other specific 5-HTT inhibitors such as fluvoxamine or citalopram or the 5-HT 1B antagonist SB224289 (3 mol/L) had no effects on the I K(V) blocking properties of 5-HT ( Figure 2C ; I-V relationships in supplemental Figure II ). Figure 3 shows hK V 1.5 current traces recorded in Ltk Ϫ cells stably expressing hK V 1.5 channels. 5-HT (10 mol/L) markedly inhibited hK V 1.5 currents to a similar extent at all potentials tested, this effect being essentially prevented by ketanserin (0.1 mol/L).
Inhibition of hK V 1.5 Currents by 5-HT
Role of Phospholipase C and Protein Kinases
To further assess the mechanisms involved in 5-HT-induced inhibition of I K(V) , PASMC were perfused with different inhibitors before and during the addition of the agonist (summarized in Figure 4 ; I-V relationships in supplemental Figure III ). The phospholipase C (PLC) inhibitor U73122 (3 mol/L) and the classic protein kinase C (PKC) inhibitor Gö6976 (0.1 mol/L) prevented the inhibitory effects of 5-HT on K V currents, whereas the PKC pseudosubstrate inhibitor (PKC-PI) (0.1 mol/L, added in the internal solution) had no effect. The tyrosine kinases inhibitor genistein (10 mol/L) per se caused a Ϸ25% inhibition of I K(V) and prevented the effects of 5-HT on the current. The inhibitory effect of genistein on I K(V) has been previously reported and seems to be independent of its tyrosine kinase inhibition activity. 28 In the presence of the more selective tyrosine kinase inhibitor tyrphostin 23 (30 mol/L), which had no effect per se, the effects of 5-HT on I K(V) were inhibited ( Figure 4B and 4C). Likewise, tyrphostin 23 prevented the inhibitory effects of 5-HT on hK V 1.5 recorded in Ltk Ϫ cells ( Figure 4D ). Furthermore, the incubation with the tyrosine phosphatase inhibitor vanadate (100 mol/L) increased the inhibitory effect of a low concentration of 5-HT (0.1 mol/L) on I K(V) in PASMC ( Figure 4E ). Taken together, these results indicated the involvement of tyrosine kinases in the electrophysiological effects of 5-HT. However, we did not find changes in the K V 1.5 protein phosphorylation in tyrosine or serine residues, whereas at least 2 bands with a molecular mass of Ϸ20 to 24 kDa that coimmunoprecipitated with K V 1.5 proteins showed increased tyrosine phosphorylation after 5 minutes of treatment with 5-HT ( Figure 4F ). Their nature is presently unknown.
K V 1.5 Association With 5-HT2A Receptors and Caveolin-1
Homogenates from PA were immunoprecipitated with anti-K V 1.5 antibodies and analyzed for 5-HT2A receptors and caveolin-1 content via Western blot analysis. Figure 5A shows that both proteins coimmunoprecipitated with K V 1.5. Furthermore, the interaction among K V 1.5, caveolin-1, and 5-HT 2A augmented after stimulation with 5-HT. To analyze the potential functional role of caveolae, PASMC were incubated with ␤-cyclodextrin (2% for 2 hours), a cholesterol-modifying agent that disrupts membrane lipid rafts. Interestingly, 5-HT failed to inhibit I K(V) in these lipid raftdisrupted myocytes ( Figure 5B and 5C ). In addition, concanavalin A, a widely used inhibitor of endocytotic processes, had no effect on I K(V) but prevented the effects of 5-HT on I K(V) ( Figure 5D ). Finally, confocal microscopy revealed that K V 1.5 channels were localized preferentially in the plasma membrane of PASMC but were partly internalized on 5-HT stimulation, and this effect was prevented with concanavalin A ( Figure 5E ).
Contractile Responses to 5-HT
Stimulation of endothelium-denuded PA rings with 5-HT (10 mol/L) induced a sustained contractile response of 113Ϯ6 mg (nϭ47). Under control conditions, the contraction elicited by 5-HT was suitably reproduced after a 30 minute washout (99Ϯ6% of the first contraction, PϾ0.05). Pretreat- ment with 0.1 mol/L ketanserin or 3 mol/L SB224289 before the second addition of 5-HT inhibited the vasoconstriction ( Figure 6A ). Fluoxetine, but not the other 5-HTT inhibitors fluvoxamine and citalopram, also caused a marked inhibition of the vasoconstriction induced by 5-HT. Furthermore, the contraction induced by 5-HT was markedly inhibited by the L-type Ca 2ϩ channel blocker nifedipine (0.1 mol/ L), the classic PKC inhibitor Gö6976 (0.1 mol/L), the tyrosine kinases inhibitors genistein (10 mol/L) or tyrphostin 23 (30 mol/L), or the endocytosis inhibitor concanavalin A (250 g/mL, Figure 6B ). In PA contracted with 5-HT (10 mol/L), addition of tyrphostin 23 (10 mol/L) induced a relaxant response of 38Ϯ8% (nϭ5; Figure 6C ). However, when arteries were stimulated by 5-HT plus the K V channel inhibitor 4-AP (10 mmol/L), tyrphostin 23 had no relaxant effect (1Ϯ1%, nϭ4; PϽ0.05).
Discussion
This is the first study demonstrating regulation of the native PA K V channels and cloned human hK V 1.5 channels by 5-HT. The main findings of the study can be summarized as follows. 5-HT depolarized PASMC and inhibited the K V current in PASMC and in Ltk Ϫ cells expressing cloned hK V 1.5 but did not modify the activation curve and the kinetics of the currents. These effects were inhibited by antagonists/inhibitors of 5-HT 2A receptors, PLC, classic PKCs, and tyrosine kinases and by cyclodextrin and concanavalin A. In addition, 5-HT 2A receptors and caveolin-1 coimmunoprecipitated with K V 1.5 channels, and K V 1.5 channels internalized when cells were stimulated with 5-HT. Finally, the contraction induced by 5-HT in isolated rat PA was inhibited by the same drugs preventing K V channels inhibition.
Decreased K V channel activity leads to depolarization, opening of L-type voltage-dependent Ca 2ϩ channels, increased [Ca 2ϩ ] i , and vasoconstriction. 16 -18 Thus, K V channel blockers such as 4-AP induce depolarization and pulmonary vasoconstriction. In the present report, 5-HT caused K V current inhibition with a similar potency (EC 50 values of Ϸ2 mol/L) than that previously reported for pulmonary vasoconstriction (EC 50 values of Ϸ1 and 3 mol/L in fawnhooded and Sprague-Dawley rats, respectively 29 ) and with a similar or higher efficacy (50% inhibition) than other vasoactive factors known to inhibit K V channels such as endothelin-1 (29% 20 ), the thromboxane A 2 analog U46619 (56% 19 ), or hypoxia (Ϸ49% 30 ). In addition, 5-HT caused membrane depolarization; its vasoconstrictor response was inhibited by the L-type Ca 2ϩ channel blocker nifedipine and by the same drugs preventing K V channel inhibition. Further- more, in 5-HT-contracted PA, the relaxation induced by the tyrosine kinase inhibitor tyrphostin 23 was abolished by 4-AP. All of these results are consistent with the view that 5-HT-induced vasoconstriction is, at least in part, mediated by K V channel inhibition. Accordingly, 5-HT has been previously reported to block K V channels in carotid body type I cells 31 and in choroid plexus epithelial cells. 32 As outlined in the introduction, multiple evidences indicate that 5-HT plays a key role in the pathogenesis of PH.
However, the molecular target of 5-HT is not clearly defined, and it seems likely that several G protein-coupled receptors, as well as the 5-HTT, are involved in PH. 5-HT-induced pulmonary vasoconstriction seems to be mainly attributable to the activation of 5-HT 2A and 5-HT 1B/1D receptors. 4, 29 In the present study, 5-HT-induced vasoconstriction was inhibited by the selective antagonists of 5-HT 2A and 5-HT 1B receptors ketanserin and SB224289, respectively, whereas the inhibition of K V currents was prevented only by ketanserin. Therefore, 5-HT-induced vasoconstriction was mediated by at least 2 types of receptors, 5-HT 2A and 5-HT 1B , but only the former signaled via K V channels. The 5-HTT inhibitor fluoxetine also inhibited the effects of 5-HT on K V currents and vasoconstriction. In contrast, other selective 5-HTT inhibitors such as fluvoxamine and citalopram at concentrations sufficient to fully inhibit the transporter had no effect. The different behavior of fluoxetine suggests that this drug is acting via a 5-HTT-independent mechanism. In fact, fluoxetine inhibited (ϩ)-norfenfluramine-and 5-HT-induced vasoconstriction in mice lacking 5-HTT. 33 One possibility is that fluoxetine antagonized 5-HT 2A receptors, because this drug, in contrast to the other 5-HTT inhibitors tested, has a relatively high affinity against the 5-HT 2A receptor (K i Ϸ140 nmol/L). 34 This drug, 1 of the most widely prescribed antidepressant, has been recently proposed as a novel treatment for PH. 13 Its inhibitory effect on 5-HT-induced K V current attenuation described herein might contribute to its ability to prevent and reverse PH. K V channels exist as tetramers formed by 4 transmembrane K V ␣ subunits 35 combined with modulatory cytosolic K V ␤ subunits. In human PA, 22 transcripts of K V ␣ (K V 1.1 to -1.7, K V 1.10, K V 2.1, K V 3.1, K V 3.3, K V 3.4, K V 4.1, K V 4.2, K V 5.1, K V 6.1 to -6.3, K V 9.1, K V 9.3, K V 10.1, and K V 11.1), and 3 of K V ␤ subunits (K V ␤1 to -3) have been identified by RT-PCR. 36 Further diversity can be found in native channels because heterotetramers can be formed by the combination of distinct K V ␣ subunits. Because K V 1.5 subunits are believed to be major contributors of the native K V currents in PA, 16 we analyzed the effects of 5-HT on the K V current carried by human cloned K V 1.5 channels expressed in Ltk Ϫ cells. 5-HT induced an inhibitory effect on this current of similar characteristics of that in native PA myocytes. This effect was also prevented by ketanserin and tyrphostin 23, suggesting a similar signaling pathway in both types of cells. In addition, we found a strong expression of 5-HT 2A receptors by Western blot in Ltk Ϫ cells (not shown). Thus, K V 1.5 channels are likely candidates to underlie 5-HT-sensitive currents in native cells, even when we cannot rule out that other K V channel subunits might also contribute to the effects of 5-HT.
In previous studies, 19, 27 we reported that K V channel inhibition induced by the thromboxane A 2 analog U46619 in both rat and porcine PA, involved the activation of PKC, an atypical PKC that is insensitive to diacylglycerol. However, 5-HT-induced inhibition of K V current was not significantly affected by the specific PKC inhibitor. 5-HT 2A receptors signal primarily through heterotrimeric proteins of the G q/11 subfamily, activation of PLC, the subsequent formation of diacylglycerol, and activation of classic diacylglycerolsensitive PKC. 37 Likewise, the effects of 5-HT on K V currents were prevented by U73122, a PLC inhibitor, and by Gö6976, an inhibitor of classic diacylglycerol-sensitive PKCs, that does not inhibit PKC and did not modify the effects of U46619 in rat PA. 19 Accordingly, K V channel inhibition by 5-HT in carotid body type I cells and rat choroid plexus epithelial cells was sensitive to PKC inhibitors. 31, 32 In addition, 5-HT-induced (but not U46619-induced) inhibition was prevented by genistein, a widely used tyrosine kinase inhibitor, and by tyrphostin 23, a selective tyrosine kinase inhib-itor. Furthermore, PA contracted by 5-HT attained a relaxant response on treatment with tyrphostin 23, suggesting that tyrosine kinase(s) is a significant player in the response to 5-HT. Incubation with the K V channel blocker 4-AP before application of tyrphostin 23 completely blocked its relaxing effect, strongly supporting the idea that K V channels are coupled to tyrosine kinase activation after 5-HT receptor stimulation. Because the degree of phosphorylation of tyrosine residues results from the balance of the phosphorylating activity of tyrosine kinases and the dephosphorylating activity of tyrosine phosphatases, it is expected that inhibition of the latter may result in an enhancement of tyrosine kinase mediated effects. In fact, the tyrosine phosphatase inhibitor vanadate potentiated the inhibitory effects of low concentrations of 5-HT on K V currents. We found no changes at the level of tyrosine or serine phosphorylation in K V 1.5 channel protein from cells incubated with 5-HT, ruling out a direct phosphorylation of K V 1.5 subunits. However, we found that 5-HT induced tyrosine phosphorylation in at least 2 unknown proteins (molecular mass of Ϸ20 to 24 kDa), which coimmunoprecipitated with K V 1.5. Taken together, these results suggest that activation of PLC, classic PKC, and tyrosine kinases are involved in the signaling pathway of 5-HT. Likewise, 5-HT 2A receptors have been coupled with activation of tyrosine kinases including Src and JAK2 via PKCdependent or -independent pathways. 38, 39 Caveolae are specialized microdomains in the plasma membrane composed of integral membrane proteins, including the protein caveolin-1, that are involved in endocytotic and signal-transduction processes. 40 Caveolae serve to compartmentalize and integrate numerous signaling events, such as PKC, tyrosine kinases, mitogen-activated protein kinase, ion channels, G proteins, and G protein-coupled receptors. 40 Caveolin has been reported to colocalize with K V 1.5 channels on the membrane of transfected Ltk Ϫ cells 41 and with 5-HT 2A receptors on the membrane of transfected HEK-293 cells and C6 glioma cells. 42 We found that K V 1.5 coimmunoprecipitated with 5-HT 2A receptors and caveolin-1 in native PA. Therefore, this association could serve to cluster the 5-HT 2A receptor and signaling proteins with the K ϩ channel, allowing for specific modulation while preventing crosstalk with other pathways. Depletion of membrane cholesterol disrupts caveolar lipid rafts without changing the amplitude of K V 1.5 currents. 41 We found that lipid raft disruption with cyclodextrin prevented the inhibitory effects of 5-HT on K V currents, indicating the functional importance of this compartmentalization. Concanavalin A binds to cell surface glycoproteins and impairs their mobility within the membrane bilayer and is widely used to block endocytotic processes, 43 including 5-HT 2A receptor endocytosis in HEK-293 cells. 44 In the present study, concanavalin A prevented the inhibitory effects on K V currents and the vasoconstriction induced by 5-HT. Likewise, endocytosis of K V 1.2 and K V 1.5 channels has been reported to be a key mechanism in the control of K V channel activity, which is regulated by tyrosine kinases. 45, 46 Confocal images of PASMC also showed that K V 1.5 immunofluorescence changed from a preferential membrane to cytosolic localization on stimulation with 5-HT, and this effect was prevented by concanavalin A. Taken together, these results suggest that the 5-HT-induced inhibition of K V currents and the subsequent vasoconstriction of PA result from the interaction of 5-HT 2A receptors with K V channels within caveolar membrane microdomains and involve tyrosine phosphorylation and endocytotic processes. This is consistent with a reduction in K V current amplitude without modification of its biophysical features.
PH has a multifactorial origin 2,47 characterized by sustained elevation of pulmonary arterial pressure associated with vasoconstriction and PA smooth muscle proliferation. Both 5-HT and K V channels have been implicated in the pathogenesis of PH. In the present study, we demonstrate that there is a link between these 2 key pathogenetic factors. Thus, 5-HT, via activation of 5-HT 2A receptors, inhibited the activity of K V channels, resulting in pulmonary vasoconstriction. Decreased K V channel activity not only causes pulmonary vasoconstriction but also contributes to pulmonary vascular medial hypertrophy by inhibiting apoptotic cell shrinkage and apoptosis, 25 whereas overexpression of the K V 1.5 gene (KCNA5) induces apoptosis in PASMC. 48 Thus, K V channel inhibition might also be involved in the medial hypertrophy of PA induced by 5-HT. 5, 49 Additionally, it must be noted that K V channel blockade has also been involved in the vasoconstriction and pulmonary hypertension induced by anorexigens and the antiparkinsonian drug pergolide. 21, 50 Interestingly, dexfenfluramine and pergolide activate 5-HT 2A receptors, 34, 51 which suggests that K V channel blockade induced by these drugs might be secondary to 5-HT 2A receptor activation.
In conclusion, 5-HT inhibits K V currents in PA myocytes and in Ltk Ϫ cells stably transfected with human K V 1.5 channels through the activation of 5-HT 2A receptors, PLC, classic PKCs, tyrosine kinases, and endocytotic processes. This effect is involved, at least partly, in PA vasoconstriction and might contribute to the development of human PH.
